Introduction
Research Ethics Committees have a duty to ensure that good ethical research is carried out. Both subjects and researchers need the protection of external ethical review. Smith to the release of their contact details to the committee as part of their consent to the study. We noticed a doctor who was doing more commercially sponsored research than his peers. Such trials are usually closely monitored by the sponsors who review the trial records and patient notes. We decided to ask the patients if some ethical standards had been met.
Methods
The committee authorized the chairman to ask the doctor for the names and addresses of all the patients he had entered in three clinical trials in the previous year. The doctor replied in ten days with 11 names and addresses. I sent the subjects a letter (appendix b), but no reminders, explaining that the committee was making a routine check on standards in research and enclosing a questionnaire (appendix c).
Results
There were ten replies over the following two months with nine completed questionnaires. One relative wrote saying that the subject was confused and unable to complete it. All nine responding patients knew they were research subjects. They all correctly identified the illness which was being treated in the trial (five hypertension, two indigestion, one depression) except one being treated for depression who chose "I'd rather not say". Two did not recall being given an information sheet but all who did understood it. Eight patients thought the researcher had answered all their questions and one was not sure. Seven subjects thought they had had enough time to consider entering the trial, one thought he had not and one was not sure. Eight subjects understood that they could have the usual treatment if they didn't want to enter the trial and one was unsure. Three subjects said they had not been told what to do if the medicine made them worse. None was offered money or gifts to enter a trial.
Discussion
The purpose of our audit was firstly to find out if such an audit could be done and secondly to make sure that ethical standards were being maintained. This is the first time we have conducted an audit in this way. I found no published account of similar work done by an ethics committee. Pharmaceutical and research companies closely monitor researchers' records but their interest is mainly in the validity of the data. We used a simple questionnaire focusing on the things we thought were important, particularly the validity of the subjects' consent. The issues which concerned us were: 1) Did the patients know that they were research subjects? 2) Had they been given enough information and enough time to give valid consent? 3) Had they been told what to do if there was a problem?
This usually requires an information sheet, including contact details of the researcher, an explicit offer of standard treatment if the subject chooses not to enter the trial, all the subject's questions answered satisfactorily and enough time to consider.
Inclusion of the response "I'd rather not say" for each question indicated that subjects did not have to answer all the questions and that this response was acceptable. It was only chosen once by a patient being treated for depression who chose not to indicate the illness for which he was being treated in the trial.
Our first objective was achieved as it was an easy task to conduct the audit. It was done with no specific funding but if we do it regularly there will be resource implications. This could be built into the charges which are levied by many LRECs.
We did not know what standard to set. Ideally there should be 1 00% compliance but in the absence of published data we used this audit to help us set standards for future audits. The committee felt the results in this small study indicated an adequate standard of ethical practice. In reaching this conclusion we made allowance for the interval between recruitment and our questionnaire, which could have resulted in inaccurate recall of events. We wrote to the doctor telling him the summarised anonymous results and our conclusion. We also emphasised that we expect all patients to be given an information sheet and enough time to consider and that they must understand clearly what to do in the event of an adverse reaction. We have not sent the results to the subjects but have sent each a letter of thanks saying that the committee was satisfied that the research was done correctly.
Audits need to be conducted with careful attention to technique. Discovery of the subjects' details from the researcher is a potential source of inaccuracy. He/she might choose not to disclose all of the subjects or he/she might try to prompt them in their responses to the questionnaire. We did nothing to stop the subjects approaching the researcher for advice on how to complete the questionnaire. There was no suggestion of impropriety in this study. If audits of this kind become more widely used, better ways of discovering and questioning the subjects will become established. Researchers might be required to send lists of subjects routinely to LRECs and questionnaires could be administered in person. Researchers who know that their research may be audited by an ethics committee will take even greater care to maintain standards.
There is a continuing debate about whether it is good for subjects to know that research has been approved by an LREC. 3 We had to reveal the existence of the LREC to obtain the subjects' consent to disclosure of contact details but there was no need to mention that the LREC had approved the research.
With increasing awareness of fraud and malpractice in research, monitoring of this kind is necessary 
